Snakebite in Nigeria: the urban face of a neglected rural disease
Nicholas Amani Hamman1,2, Aashna Uppal3, Nuhu Mohammed1, Abigail Micah Umar1, Trudie Lang3, Joshua Abubakar Difa2 1 Snakebite Treatment and ...
Articles
Intergenerational associations of stigma toward receiving psychological help in rural communities: The roles of fathers and mothers in shaping emerging adults’ attitudes.
Stigma toward receiving psychological help remains a major barrier to service use in rural and low-resource settings, yet little is known about how such stigma is transmitted within families. This ...
Screening-to-intervention pathway for child anxiety problems alongside usual school practice versus usual school practice only (iCATSi2i)
A cluster-randomised, controlled trial in primary schools in England Screening for anxiety problems in primary schools and offering parent-led cognitive behavioural therapy (CBT) via online and telephone support for those ...
UKHSA strengthens data-driven local surveillance capacity for early response in Mardan district
Health workers in Mardan District, Pakistan, have begun using community surveillance data to trigger outbreak responses independently, following practical training supported by UKHSA earlier this year. Since implementation began, two ...
Digital approaches to enhancing community engagement in clinical trials
Clinical trials are becoming increasingly digital, yet efforts to strengthen community engagement have not always kept pace with this shift. While technology is now commonly used for recruitment, data ...
News
EDCTP3 and CEPI as contributing partner have launched a Call for Proposal for “Training networks for sustained capacity building related to ethics, regulatory and pharmacovigilance” in sub-Saharan Africa
Deadline for application: 2 September 2026
Proposed projects will be expected to increase regulatory and research ethics oversight capacity of national and regional authorities in SSA to operate at WHO maturity level 3 for clinical trial, registration and/or PV for medical products (therapeutics/vaccines) Read more
CEPI is establishing the Biospecimen Sourcing Initiative (BSI)
The BSI will help facilitate the timely and ethical collection of biological samples in an outbreak. The BSI aims to make biospecimens available to develop assays and standards within weeks, rather than the six months it typically takes today. Read more
CEPI launches new Biosecurity Policy
CEPI has published its first Biosecurity Policy, strengthening safe, responsible, and equitable research. The Policy outlines clear biosecurity and biosafety requirements for Third Parties, supporting our mission to advance global health preparedness and protect communities through secure scientific innovation. Read more
CEPI launches a Call for Proposal for innovative analytical technologies to improve vaccine manufacturing speed and equitable access
Deadline for application: 1 May 2026. An application may be submitted at any time; the review process will involve quarterly reviews throughout the 12-month application period
CEPI has announced a funding opportunity to develop innovative analytical technologies for vaccines. The goal is to reduce vaccine development, manufacturing, and release times; lower costs, improve equitable deployment in Low to Middle-Income Countries, and enhance analytical insights for vaccines. Read more
Announcing the Lassa Fever Vaccine Policy Research Agenda
The publication of the first-ever Lassa Fever Vaccine Policy Research Agenda is a landmark achievement for regional health security and vaccine preparedness in West Africa
It aims to guide researchers, funders, and policymakers in aligning ongoing and future studies with the most pressing policy needs. The agenda also aims to strengthen coordination and ensure that new evidence directly informs national and regional vaccine readiness decisions. Read more
CEPI has launched the Research Preparedness Program (RPP)
The RPP will support both advanced-stage clinical development of CEPI’s portfolio vaccines against priority diseases and the 100 Days Mission
The objective of the RPP is to leverage investments for advanced-stage clinical development of CEPI's portfolio vaccines and support countries in key regions to generate emergency evidence in future outbreaks Read more
| Older News Here |
Resources
Pandemic Preparedness & Response Playbook
In collaboration with TGHN, CEPI created this playbook to bring together the many tools, resources and materials generated for pandemic preparedness and response from the COVID-19 pandemic. The first (Regulatory) chapter is now available.
TRANSVAC Academy Training Courses
TRANSVAC Academy offers training modules in vaccine R&D including grant management, statistics, cytometry and advanced process development. CEPI funded scholarships are provided to selected applicants from LMICs.
SPEAC: THE SAFETY PLATFORM FOR EMERGENCY VACCINES
SPEAC is a CEPI and Brighton Collaboration project. SPEAC provides vaccine safety tools, resources, and expertise throughout the vaccine development process to enhance safety and build confidence in vaccines.
Monitoring Vaccine Performance against SARS CoV-2 Variants
The IVAC COVID-19 Vaccine Effectiveness Project (a CEPI- funded global systematic review which also includes neutralization capacity) outputs are publicly available on VIEWhub to assist all policy makers
International Pandemic Preparedness Secretariat
The IPPS serves to join up relevant states, the private sector, and global health institutions in support of the 100 Days Mission, across vaccines, therapeutics, and diagnostics. It performs a global annual progress review related to the 100 DM which feeds into implementation reports.
Vaccine Development
Process Maps
The UK Vaccine R&D Network has developed vaccine development maps to show key stages in human and veterinary vaccines development up to Phase III clinical trials. These process maps and associated case studies provide support in understanding key stages in vaccine development and where bottlenecks could cause delays.
